Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Current Liabilities (2016 - 2025)

Veracyte's Total Current Liabilities history spans 14 years, with the latest figure at $75.1 million for Q1 2025.

  • For Q1 2025, Total Current Liabilities rose 29.41% year-over-year to $75.1 million; the TTM value through Mar 2025 reached $75.1 million, up 29.41%, while the annual FY2024 figure was $78.6 million, 28.4% up from the prior year.
  • Total Current Liabilities for Q1 2025 was $75.1 million at Veracyte, down from $78.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $78.6 million in Q4 2024 and bottomed at $36.1 million in Q2 2021.
  • The 5-year median for Total Current Liabilities is $61.9 million (2022), against an average of $61.6 million.
  • The largest annual shift saw Total Current Liabilities surged 282.28% in 2021 before it decreased 2.4% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $64.2 million in 2021, then fell by 2.4% to $62.6 million in 2022, then decreased by 2.19% to $61.2 million in 2023, then increased by 28.4% to $78.6 million in 2024, then decreased by 4.46% to $75.1 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Total Current Liabilities are $75.1 million (Q1 2025), $78.6 million (Q4 2024), and $58.1 million (Q1 2024).